The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 31, 2026 | Cutler Andrew Jon | Director | Grant(A) | 472K | — | $0 |
| Jun 29, 2026 | Philipson Tomas Jan | Director | Grant(A) | 536K | — | $0 |
| Jun 2, 2026 | Weis Holger | Director | Grant(A) | 100K | — | $0 |
| Jun 2, 2026 | Rosen Alexander Gustaf Erik | Chief Administrative Officer | Grant(A) | 342K | — | $0 |
| Jun 2, 2026 | Elmasri Saleem | Chief Financial Officer | Grant(A) | 526K | — | $0 |
| Jun 2, 2026 | Rosen Christer | CEO and Chairman, Director | Grant(A) | 748K | — | $0 |
| Jun 2, 2026 | Hemmerly Nicholas H. | Director | Grant(A) | 100K | — | $0 |
| Jun 2, 2026 | Kampf Julie B. | Director | Grant(A) | 100K | — | $0 |
| Jun 2, 2026 | Silva Alison D. | President and COO, Director | Grant(A) | 1.0M | — | $0 |
| Jun 2, 2026 | Hayward Marshall A. | Chief Scientific Officer, Director | Grant(A) | 259K | — | $0 |
| Jun 2, 2026 | Brady Allison W | Director | Grant(A) | 100K | — | $0 |
| Mar 2, 2026 | Hayward Marshall A. | Chief Scientific Officer, Director | Option exercise(M) | 225K | — | — |
| Mar 2, 2026 | Hayward Marshall A. | Chief Scientific Officer, Director | Option exercise(M) | 225K | — | $0 |
| Jul 2, 2025 | Silva Alison D. | Pres + Chief Business Officer | Grant(A) | 255K | — | — |
| Jul 2, 2025 | Elmasri Saleem | CFO and Secretary | Grant(A) | 102K | — | — |
| Jul 1, 2025 | Rosen Christer | CEO and Chairman, Director, 10% Owner | Buy(P) | 500 | $1.01 | $505 |
| Jul 1, 2025 | Rosen Christer | CEO and Chairman, Director, 10% Owner | Buy(P) | 3K | $1.02 | $3K |
| Jul 1, 2025 | Silva Alison D. | Pres + Chief Business Officer, Director | Buy(P) | 250 | $1.03 | $258 |
| Jul 1, 2025 | Silva Alison D. | Pres + Chief Business Officer, Director | Buy(P) | 250 | $1.03 | $258 |
| Jul 1, 2025 | Silva Alison D. | Pres + Chief Business Officer, Director | Buy(P) | 250 | $1.03 | $258 |
| Jun 30, 2025 | Rosen Christer | CEO and Chairman, Director, 10% Owner | Buy(P) | 1K | $1.05 | $1K |
| Jun 30, 2025 | Rosen Christer | CEO and Chairman, Director, 10% Owner | Buy(P) | 2K | $1.04 | $2K |
| Jun 30, 2025 | Rosen Christer | CEO and Chairman, Director, 10% Owner | Buy(P) | 700 | $1.03 | $721 |
| Jun 30, 2025 | Rosen Christer | CEO and Chairman, Director, 10% Owner | Buy(P) | 2K | $1.01 | $2K |
| Jun 30, 2025 | Rosen Christer | CEO and Chairman, Director, 10% Owner | Buy(P) | 1K | $0.98 | $980 |
| Jun 30, 2025 | Rosen Christer | CEO and Chairman, Director, 10% Owner | Buy(P) | 1K | $1.02 | $1K |
| Jun 30, 2025 | Silva Alison D. | Pres + Chief Business Officer, Director | Buy(P) | 100 | $1.05 | $105 |
| Jun 30, 2025 | Silva Alison D. | Pres + Chief Business Officer, Director | Buy(P) | 100 | $1.02 | $102 |
| Jun 30, 2025 | Silva Alison D. | Pres + Chief Business Officer, Director | Buy(P) | 250 | $1.02 | $255 |
| Jun 30, 2025 | Silva Alison D. | Pres + Chief Business Officer, Director | Buy(P) | 250 | $1.03 | $258 |
| Jun 30, 2025 | Silva Alison D. | Pres + Chief Business Officer, Director | Buy(P) | 250 | $1.04 | $260 |
| Jun 27, 2025 | Rosen Christer | CEO and Chairman, Director, 10% Owner | Buy(P) | 166 | $1.06 | $176 |
| Jun 27, 2025 | Silva Alison D. | Pres + Chief Business Officer, Director | Buy(P) | 250 | $1.00 | $250 |
| Jun 27, 2025 | Silva Alison D. | Pres + Chief Business Officer, Director | Buy(P) | 100 | $1.04 | $104 |
| Jun 27, 2025 | Silva Alison D. | Pres + Chief Business Officer, Director | Buy(P) | 250 | $1.04 | $260 |
| Jun 27, 2025 | Silva Alison D. | Pres + Chief Business Officer, Director | Buy(P) | 250 | $1.05 | $263 |
| Jun 2, 2025 | Rosen Christer | CEO and Chairman, Director, 10% Owner | Option exercise(M) | 497K | — | $0 |
| Jun 2, 2025 | Rosen Christer | CEO and Chairman, Director, 10% Owner | Option exercise(M) | 476K | — | $0 |
| Jun 2, 2025 | Silva Alison D. | Pres + Chief Business Officer, Director | Option exercise(M) | 110K | — | $0 |
| Jun 2, 2025 | Elmasri Saleem | CFO and Secretary | Option exercise(M) | 66K | — | $0 |
| Jun 2, 2025 | Kampf Julie B. | Director | Option exercise(M) | 83K | — | — |
| Jun 2, 2025 | Kampf Julie B. | Director | Option exercise(M) | 83K | — | $0 |
| Jun 2, 2025 | Rosen Alexander Gustaf Erik | Chief Administrative Officer | Option exercise(M) | 165K | — | — |
| Jun 2, 2025 | Rosen Alexander Gustaf Erik | Chief Administrative Officer | Option exercise(M) | 97K | — | — |
| Jun 2, 2025 | Rosen Alexander Gustaf Erik | Chief Administrative Officer | Option exercise(M) | 165K | — | $0 |
| Jun 2, 2025 | Rosen Alexander Gustaf Erik | Chief Administrative Officer | Option exercise(M) | 97K | — | $0 |
| Jun 2, 2025 | Hayward Marshall A. | Chief Scientific Officer, Director | Option exercise(M) | 390K | — | — |
| Jun 2, 2025 | Hayward Marshall A. | Chief Scientific Officer, Director | Option exercise(M) | 399K | — | — |
| Jun 2, 2025 | Hayward Marshall A. | Chief Scientific Officer, Director | Option exercise(M) | 390K | — | $0 |
| Jun 2, 2025 | Hayward Marshall A. | Chief Scientific Officer, Director | Option exercise(M) | 399K | — | $0 |
| Jun 2, 2025 | Hemmerly Nicholas H. | Director | Option exercise(M) | 96K | — | — |
| Jun 2, 2025 | Hemmerly Nicholas H. | Director | Option exercise(M) | 96K | — | $0 |
| Jun 2, 2025 | Weis Holger | Director | Option exercise(M) | 86K | — | — |
| Jun 2, 2025 | Weis Holger | Director | Option exercise(M) | 86K | — | $0 |
| Jan 22, 2025 | Brady Allison W | Director | Option exercise(M) | 22K | — | — |
| Jan 22, 2025 | Brady Allison W | Director | Option exercise(M) | 22K | $2.80 | $61K |
| Jan 22, 2025 | Weis Holger | Director | Option exercise(M) | 11K | — | — |
| Jan 22, 2025 | Weis Holger | Director | Option exercise(M) | 11K | $2.80 | $30K |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Issuer: Jupiter Neurosciences, Inc., SEC CIK 0001679628. The symbol on a Form 4 is typed by the filer, so this page follows the issuer with the newest filing under JUNS and shows every filing by that issuer.
Coverage: Form 4 filings indexed 2006-01-02 → 2026-09-12. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).
Connected pages for JUNS